secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVAI BIO, INC. (AVAI)
CIK:        0001740797
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001740797-24-000003
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avant Technologies hires Jared Pelski as VP of Business Development with $200K salary and equity incentives
--------------------------------------------------------------------------------

- Jared Pelski appointed Vice President – Business Development effective January 17, 2024.
- Base salary of $200,000 per year, annual cash bonus up to 25% of base, and one-time $25,000 sign-on bonus.
- Initial ISO grant for 0.6% of outstanding common stock at $0.01 strike price, 4-year vesting with 1-year cliff.
- Eligible for Restricted Stock Awards at 15% discount to VWAP; up-listing bonus of $300,000 RSA if Nasdaq-listed.
- Commission on sales and origination bonus for capital raised using Lehman scale.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740797/000174079724000003/0001740797-24-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740797/000174079724000003/avai8k_j.htm
  HTML page:      https://secwatch.observer/filing/0001740797-24-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer